1 | 1 | | 1.1 A bill for an act |
---|
2 | 2 | | 1.2 relating to health care; requiring disclosure of certain health care provider |
---|
3 | 3 | | 1.3 reimbursement arrangements to enrollees and health care providers; modifying |
---|
4 | 4 | | 1.4 the duties of the ombudsperson for public managed health care programs; providing |
---|
5 | 5 | | 1.5 health carrier liability when a health care provider is limited in providing services |
---|
6 | 6 | | 1.6 by the health carrier; amending Minnesota Statutes 2024, sections 62J.72, |
---|
7 | 7 | | 1.7 subdivision 1; 62Q.735, subdivision 1; proposing coding for new law in Minnesota |
---|
8 | 8 | | 1.8 Statutes, chapter 604. |
---|
9 | 9 | | 1.9BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA: |
---|
10 | 10 | | 1.10 Section 1. Minnesota Statutes 2024, section 62J.72, subdivision 1, is amended to read: |
---|
11 | 11 | | 1.11 Subdivision 1.Written disclosure.(a) A health plan company, as defined under section |
---|
12 | 12 | | 1.1262J.70, subdivision 3,; a health care network cooperative, as defined under section 62R.04, |
---|
13 | 13 | | 1.13subdivision 3, and; a health care provider, as defined under section 62J.70, subdivision 2,; |
---|
14 | 14 | | 1.14and all payers that use value-based payment shall, during open enrollment, upon enrollment, |
---|
15 | 15 | | 1.15and annually thereafter, provide enrollees with a description of the general nature of the |
---|
16 | 16 | | 1.16reimbursement methodologies used by the health plan company, health insurer, or health |
---|
17 | 17 | | 1.17coverage plan to pay providers. The description must explain clearly any aspect of the |
---|
18 | 18 | | 1.18reimbursement methodology that creates a financial incentive for the health care provider |
---|
19 | 19 | | 1.19to limit or restrict the health care provided to enrollees., including any aspect of a |
---|
20 | 20 | | 1.20reimbursement methodology in which: |
---|
21 | 21 | | 1.21 (1) payments to health care providers are based on the volume of care provided or the |
---|
22 | 22 | | 1.22number of referrals to or utilization of specialists; |
---|
23 | 23 | | 1.23 (2) providers provide services to a specified patient population for an agreed-upon total |
---|
24 | 24 | | 1.24cost of care or are reimbursed under a risk/gain sharing payment arrangement; or |
---|
25 | 25 | | 1Section 1. |
---|
26 | 26 | | 25-01662 as introduced01/03/25 REVISOR SGS/VJ |
---|
27 | 27 | | SENATE |
---|
28 | 28 | | STATE OF MINNESOTA |
---|
29 | 29 | | S.F. No. 1107NINETY-FOURTH SESSION |
---|
30 | 30 | | (SENATE AUTHORS: GRUENHAGEN) |
---|
31 | 31 | | OFFICIAL STATUSD-PGDATE |
---|
32 | 32 | | Introduction and first reading02/06/2025 |
---|
33 | 33 | | Referred to Health and Human Services 2.1 (3) provider reimbursement is based on provider tiering, with providers assigned to tiers |
---|
34 | 34 | | 2.2based on the cost of care provided, the volume of care provided, or the number of referrals |
---|
35 | 35 | | 2.3to or utilization of specialists. |
---|
36 | 36 | | 2.4The description must also clearly explain how the reimbursement methodology operates to |
---|
37 | 37 | | 2.5limit or restrict, or may have the effect of limiting or restricting, the health care provided |
---|
38 | 38 | | 2.6to enrollees and the specific limitations or restrictions of health care that enrollees may |
---|
39 | 39 | | 2.7experience. An entity required to disclose shall also disclose if no reimbursement |
---|
40 | 40 | | 2.8methodology is used that creates a financial incentive for the health care provider to limit |
---|
41 | 41 | | 2.9or restrict the health care provided to enrollees. This description may be incorporated into |
---|
42 | 42 | | 2.10the member handbook, subscriber contract, certificate of coverage, or other written enrollee |
---|
43 | 43 | | 2.11communication. The general reimbursement methodology shall be made available to |
---|
44 | 44 | | 2.12employers at the time of open enrollment. |
---|
45 | 45 | | 2.13 (b) Health plan companies, health care network cooperatives, and providers must, upon |
---|
46 | 46 | | 2.14request, provide an enrollee with specific information regarding the reimbursement |
---|
47 | 47 | | 2.15methodology, including, but not limited to, the following information: |
---|
48 | 48 | | 2.16 (1) a concise written description of the provider payment plan, including any incentive |
---|
49 | 49 | | 2.17plan applicable to the enrollee; |
---|
50 | 50 | | 2.18 (2) a written description of any incentive to the provider relating to the provision of |
---|
51 | 51 | | 2.19health care services to enrollees, including any compensation arrangement that is dependent |
---|
52 | 52 | | 2.20on the amount of health coverage or health care services provided to the enrollee, or the |
---|
53 | 53 | | 2.21number of referrals to or utilization of specialists; and |
---|
54 | 54 | | 2.22 (3) a written description of any incentive plan that involves the transfer of financial risk |
---|
55 | 55 | | 2.23to the health care provider. |
---|
56 | 56 | | 2.24 (c) The disclosure statement under paragraph (a) describing the general nature of the |
---|
57 | 57 | | 2.25reimbursement methodologies must comply with the Readability of Insurance Policies Act |
---|
58 | 58 | | 2.26in chapter 72C and must be filed with and approved by the commissioner prior to its use. |
---|
59 | 59 | | 2.27 (d) A disclosure statement that has been filed with the commissioner for approval under |
---|
60 | 60 | | 2.28paragraph (c) is deemed approved 30 days after the date of filing, unless approved or |
---|
61 | 61 | | 2.29disapproved by the commissioner on or before the end of that 30-day period. |
---|
62 | 62 | | 2.30 (e) The disclosure statement under paragraph (a) describing the general nature of the |
---|
63 | 63 | | 2.31reimbursement methodologies must be provided upon request in English, Spanish, |
---|
64 | 64 | | 2.32Vietnamese, and Hmong. In addition, reasonable efforts must be made to provide information |
---|
65 | 65 | | 2.33contained in the disclosure statement to other non-English-speaking enrollees. |
---|
66 | 66 | | 2Section 1. |
---|
67 | 67 | | 25-01662 as introduced01/03/25 REVISOR SGS/VJ 3.1 (f) Health plan companies and providers may enter into agreements to determine how |
---|
68 | 68 | | 3.2to respond to enrollee requests received by either the provider or the health plan company. |
---|
69 | 69 | | 3.3This subdivision does not require disclosure of specific amounts paid to a provider, provider |
---|
70 | 70 | | 3.4fee schedules, provider salaries, or other proprietary information of a specific health plan |
---|
71 | 71 | | 3.5company or health insurer or health coverage plan or provider. The disclosures required by |
---|
72 | 72 | | 3.6the subdivision are deemed to not constitute disclosures of proprietary or trade secret |
---|
73 | 73 | | 3.7information. |
---|
74 | 74 | | 3.8 EFFECTIVE DATE.This section is effective January 1, 2025. |
---|
75 | 75 | | 3.9 Sec. 2. Minnesota Statutes 2024, section 62Q.735, subdivision 1, is amended to read: |
---|
76 | 76 | | 3.10 Subdivision 1.Contract disclosure.(a) Before requiring a health care provider to sign |
---|
77 | 77 | | 3.11a contract, a health plan company shall give to the provider a complete copy of the proposed |
---|
78 | 78 | | 3.12contract, including: |
---|
79 | 79 | | 3.13 (1) all attachments and exhibits; |
---|
80 | 80 | | 3.14 (2) operating manuals; |
---|
81 | 81 | | 3.15 (3) a general description of the health plan company's health service coding guidelines |
---|
82 | 82 | | 3.16and requirement for procedures and diagnoses with modifiers, and multiple procedures; and |
---|
83 | 83 | | 3.17 (4) all guidelines and treatment parameters incorporated or referenced in the contract. |
---|
84 | 84 | | 3.18 (b) The health plan company shall make available to the provider: |
---|
85 | 85 | | 3.19 (1) the fee schedule or a method or process that allows the provider to determine the fee |
---|
86 | 86 | | 3.20schedule for each health care service to be provided under the contract.; and |
---|
87 | 87 | | 3.21 (2) a description of any conditions in the contract that are related to provider |
---|
88 | 88 | | 3.22reimbursement and that may have the effect of limiting or restricting the health care services |
---|
89 | 89 | | 3.23the provider provides to enrollees. |
---|
90 | 90 | | 3.24 (c) Nothing in this section requires a dental plan organization to disclose the plan's |
---|
91 | 91 | | 3.25aggregate maximum allowable fee table used to determine other providers' fees. The |
---|
92 | 92 | | 3.26contracted provider must not release this information in any way that would violate any |
---|
93 | 93 | | 3.27state or federal antitrust law. |
---|
94 | 94 | | 3.28 (d) The disclosures required by this subdivision are deemed to not constitute disclosures |
---|
95 | 95 | | 3.29of proprietary or trade secret information. |
---|
96 | 96 | | 3.30 EFFECTIVE DATE.This section is effective January 1, 2025. |
---|
97 | 97 | | 3Sec. 2. |
---|
98 | 98 | | 25-01662 as introduced01/03/25 REVISOR SGS/VJ 4.1 Sec. 3. [604.112] HEALTH CARRIER LIABILITY. |
---|
99 | 99 | | 4.2 Subdivision 1.Definition.For purposes of this section, "health carrier" has the meaning |
---|
100 | 100 | | 4.3given in section 62A.011, subdivision 2. |
---|
101 | 101 | | 4.4 Subd. 2.Liability.If a health carrier agrees to compensate a health care provider for |
---|
102 | 102 | | 4.5the provision of services to a patient and the amount of the compensation is conditioned by |
---|
103 | 103 | | 4.6a limit on the amount of services to be provided by the provider, then the health carrier is |
---|
104 | 104 | | 4.7liable for an injury to a patient caused in whole or in part by a delay or denial of care if the |
---|
105 | 105 | | 4.8delay or denial of care was a consequence of the limit. |
---|
106 | 106 | | 4.9 Subd. 3.Information on reimbursement methodology.Disclosure in an action brought |
---|
107 | 107 | | 4.10under this section of information on the reimbursement methodology used by a health carrier |
---|
108 | 108 | | 4.11to compensate a health care provider is deemed to not constitute the disclosure of proprietary |
---|
109 | 109 | | 4.12or trade secret information. |
---|
110 | 110 | | 4.13 EFFECTIVE DATE.This section is effective for causes of action accruing on or after |
---|
111 | 111 | | 4.14August 1, 2025. |
---|
112 | 112 | | 4Sec. 3. |
---|
113 | 113 | | 25-01662 as introduced01/03/25 REVISOR SGS/VJ |
---|